HEADER OXIDOREDUCTASE 17-MAY-02 1LSJ TITLE CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3-HYDROXYACYL-COA TITLE 2 DEHYDROGENASE IN COMPLEX WITH NAD COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3-HYDROXYACYL-COA DEHYDROGENASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: L-3-HYDROXYACYL-COA DEHYDROGENASE, SHORT CHAIN 3- COMPND 5 HYDROXYACYL-COA DEHYDROGENASE, HCDH; COMPND 6 EC: 1.1.1.35; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HCDH; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ROSSMANN FOLD, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR J.J.BARYCKI,L.J.BANASZAK REVDAT 4 27-OCT-21 1LSJ 1 REMARK SEQADV REVDAT 3 04-APR-18 1LSJ 1 REMARK REVDAT 2 24-FEB-09 1LSJ 1 VERSN REVDAT 1 03-FEB-04 1LSJ 0 JRNL AUTH J.J.BARYCKI,L.J.BANASZAK JRNL TITL CRYSTAL STRUCTURE OF THE E110Q MUTANT OF L-3-HYDROXYACYL-COA JRNL TITL 2 DEHYDROGENASE IN COMPLEX WITH NAD JRNL REF TO BE PUBLISHED JRNL REFN REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.J.BARYCKI,L.K.O'BRIEN,J.M.BRATT,R.ZHANG,R.SANISHVILI, REMARK 1 AUTH 2 A.W.STRAUSS,L.J.BANASZAK REMARK 1 TITL BIOCHEMICAL CHARACTERIZATION AND CRYSTAL STRUCTURE REMARK 1 TITL 2 DETERMINATION OF HUMAN HEART SHORT CHAIN L-3-HYDROXYACYL-COA REMARK 1 TITL 3 DEHYDROGENASE PROVIDE INSIGHTS INTO CATALYTIC MECHANISM REMARK 1 REF BIOCHEMISTRY V. 38 5786 1999 REMARK 1 REFN ISSN 0006-2960 REMARK 1 DOI 10.1021/BI9829027 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 25678 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1236 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4009 REMARK 3 BIN R VALUE (WORKING SET) : 0.2720 REMARK 3 BIN FREE R VALUE : 0.3320 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.80 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 204 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 159 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.80 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.00000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.32 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.43 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.840 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.140 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.950 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.660 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.580 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 24.11 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NAD_MOD.PARAM REMARK 3 PARAMETER FILE 4 : CAA_IDEAL_50.PARAM REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NAD.TOP REMARK 3 TOPOLOGY FILE 4 : CAA.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1LSJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-MAY-02. REMARK 100 THE DEPOSITION ID IS D_1000016242. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTAL CLEAR / D*TREK, REMARK 200 CRYSTALCLEAR D*TREK (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR D*TREK (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25717 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 28.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 200 DATA REDUNDANCY : 4.770 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.75 REMARK 200 R MERGE FOR SHELL (I) : 0.23100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 7.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 3HAD REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM N-[2-ACETAMIDO]-2-IMINODIACETIC REMARK 280 ACID WITHIN THE PRECIPITANT RANGE OF 14% TO 19% POLYETHYLENE REMARK 280 GLYCOL 4000, PH 6.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.01000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.25250 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.97500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.25250 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.01000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.97500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICALLY RELEVANT DIMER CONTAINED WITHIN THE ASYMMETRIC REMARK 300 UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5400 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25110 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -40.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1 REMARK 465 SER A 2 REMARK 465 SER A 3 REMARK 465 SER A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 SER A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 ALA A 10 REMARK 465 LYS A 11 REMARK 465 SER B 1 REMARK 465 SER B 2 REMARK 465 SER B 3 REMARK 465 SER B 4 REMARK 465 THR B 5 REMARK 465 ALA B 6 REMARK 465 SER B 7 REMARK 465 ALA B 8 REMARK 465 SER B 9 REMARK 465 ALA B 10 REMARK 465 LYS B 11 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 68 31.90 -89.81 REMARK 500 LYS A 69 -46.36 -155.41 REMARK 500 ASN A 73 73.05 -175.18 REMARK 500 ILE A 88 74.46 -108.08 REMARK 500 ILE A 108 -165.15 -113.51 REMARK 500 GLN A 110 66.15 -63.55 REMARK 500 ALA A 126 156.68 -49.35 REMARK 500 THR A 130 131.38 -36.15 REMARK 500 PHE A 205 -132.99 53.02 REMARK 500 ILE A 206 -77.53 -87.92 REMARK 500 ASP A 269 50.07 -161.66 REMARK 500 ALA A 270 -32.42 -36.11 REMARK 500 ASN B 73 69.74 -156.87 REMARK 500 SER B 100 31.36 -140.99 REMARK 500 VAL B 109 135.59 -38.16 REMARK 500 GLN B 110 46.59 -72.09 REMARK 500 PHE B 205 -104.81 54.62 REMARK 500 ILE B 206 -64.75 -122.04 REMARK 500 LYS B 289 79.99 -110.03 REMARK 500 LYS B 293 40.37 -69.56 REMARK 500 THR B 294 -25.75 -165.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD A 350 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAD B 750 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3HAD RELATED DB: PDB REMARK 900 3HAD IS THE WILD-TYPE L-HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX REMARK 900 WITH NAD REMARK 900 RELATED ID: 1LSO RELATED DB: PDB REMARK 900 1LSO IS THE CRYSTAL STRUCTURE OF THE S137A MUTANT OF L-3- REMARK 900 HYDROXYACYL-COA DEHYDROGENASE IN COMPLEX WITH NAD DBREF 1LSJ A 1 302 UNP Q16836 HCDH_HUMAN 7 308 DBREF 1LSJ B 1 302 UNP Q16836 HCDH_HUMAN 7 308 SEQADV 1LSJ GLN A 110 UNP Q16836 GLU 116 ENGINEERED MUTATION SEQADV 1LSJ GLN B 110 UNP Q16836 GLU 116 ENGINEERED MUTATION SEQRES 1 A 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 A 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 A 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 A 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 A 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 A 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 A 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 A 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 A 302 VAL GLU ALA ILE VAL GLN ASN LEU LYS VAL LYS ASN GLU SEQRES 10 A 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 A 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 A 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 A 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 A 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 A 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 A 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 A 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 A 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 A 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 A 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 A 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 A 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 A 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 A 302 LYS TYR LYS SEQRES 1 B 302 SER SER SER SER THR ALA SER ALA SER ALA LYS LYS ILE SEQRES 2 B 302 ILE VAL LYS HIS VAL THR VAL ILE GLY GLY GLY LEU MET SEQRES 3 B 302 GLY ALA GLY ILE ALA GLN VAL ALA ALA ALA THR GLY HIS SEQRES 4 B 302 THR VAL VAL LEU VAL ASP GLN THR GLU ASP ILE LEU ALA SEQRES 5 B 302 LYS SER LYS LYS GLY ILE GLU GLU SER LEU ARG LYS VAL SEQRES 6 B 302 ALA LYS LYS LYS PHE ALA GLU ASN PRO LYS ALA GLY ASP SEQRES 7 B 302 GLU PHE VAL GLU LYS THR LEU SER THR ILE ALA THR SER SEQRES 8 B 302 THR ASP ALA ALA SER VAL VAL HIS SER THR ASP LEU VAL SEQRES 9 B 302 VAL GLU ALA ILE VAL GLN ASN LEU LYS VAL LYS ASN GLU SEQRES 10 B 302 LEU PHE LYS ARG LEU ASP LYS PHE ALA ALA GLU HIS THR SEQRES 11 B 302 ILE PHE ALA SER ASN THR SER SER LEU GLN ILE THR SER SEQRES 12 B 302 ILE ALA ASN ALA THR THR ARG GLN ASP ARG PHE ALA GLY SEQRES 13 B 302 LEU HIS PHE PHE ASN PRO VAL PRO VAL MET LYS LEU VAL SEQRES 14 B 302 GLU VAL ILE LYS THR PRO MET THR SER GLN LYS THR PHE SEQRES 15 B 302 GLU SER LEU VAL ASP PHE SER LYS ALA LEU GLY LYS HIS SEQRES 16 B 302 PRO VAL SER CYS LYS ASP THR PRO GLY PHE ILE VAL ASN SEQRES 17 B 302 ARG LEU LEU VAL PRO TYR LEU MET GLU ALA ILE ARG LEU SEQRES 18 B 302 TYR GLU ARG GLY ASP ALA SER LYS GLU ASP ILE ASP THR SEQRES 19 B 302 ALA MET LYS LEU GLY ALA GLY TYR PRO MET GLY PRO PHE SEQRES 20 B 302 GLU LEU LEU ASP TYR VAL GLY LEU ASP THR THR LYS PHE SEQRES 21 B 302 ILE VAL ASP GLY TRP HIS GLU MET ASP ALA GLU ASN PRO SEQRES 22 B 302 LEU HIS GLN PRO SER PRO SER LEU ASN LYS LEU VAL ALA SEQRES 23 B 302 GLU ASN LYS PHE GLY LYS LYS THR GLY GLU GLY PHE TYR SEQRES 24 B 302 LYS TYR LYS HET NAD A 350 44 HET NAD B 750 44 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE FORMUL 3 NAD 2(C21 H27 N7 O14 P2) FORMUL 5 HOH *159(H2 O) HELIX 1 1 GLY A 24 THR A 37 1 14 HELIX 2 2 THR A 47 LYS A 68 1 22 HELIX 3 3 ASN A 73 THR A 87 1 15 HELIX 4 4 ASP A 93 THR A 101 5 9 HELIX 5 5 ASN A 111 ALA A 126 1 16 HELIX 6 6 GLN A 140 ASN A 146 1 7 HELIX 7 7 ARG A 150 ASP A 152 5 3 HELIX 8 8 SER A 178 LEU A 192 1 15 HELIX 9 9 ILE A 206 ARG A 224 1 19 HELIX 10 10 SER A 228 GLY A 241 1 14 HELIX 11 11 GLY A 245 GLY A 254 1 10 HELIX 12 12 GLY A 254 MET A 268 1 15 HELIX 13 13 ASN A 272 GLN A 276 5 5 HELIX 14 14 SER A 278 GLU A 287 1 10 HELIX 15 15 GLY A 291 GLY A 295 5 5 HELIX 16 16 GLY B 24 THR B 37 1 14 HELIX 17 17 THR B 47 PHE B 70 1 24 HELIX 18 18 ASN B 73 SER B 86 1 14 HELIX 19 19 ASP B 93 VAL B 98 1 6 HELIX 20 20 HIS B 99 THR B 101 5 3 HELIX 21 21 ASN B 111 LYS B 124 1 14 HELIX 22 22 GLN B 140 ASN B 146 1 7 HELIX 23 23 ARG B 150 ASP B 152 5 3 HELIX 24 24 SER B 178 LEU B 192 1 15 HELIX 25 25 ILE B 206 ARG B 224 1 19 HELIX 26 26 SER B 228 GLY B 241 1 14 HELIX 27 27 GLY B 245 GLY B 254 1 10 HELIX 28 28 GLY B 254 ASP B 269 1 16 HELIX 29 29 ASN B 272 GLN B 276 5 5 HELIX 30 30 SER B 278 GLU B 287 1 10 SHEET 1 A 8 ILE A 88 SER A 91 0 SHEET 2 A 8 THR A 40 VAL A 44 1 N LEU A 43 O ALA A 89 SHEET 3 A 8 HIS A 17 ILE A 21 1 N VAL A 18 O THR A 40 SHEET 4 A 8 LEU A 103 GLU A 106 1 O LEU A 103 N THR A 19 SHEET 5 A 8 ILE A 131 SER A 134 1 O ALA A 133 N VAL A 104 SHEET 6 A 8 PHE A 154 PHE A 159 1 O ALA A 155 N PHE A 132 SHEET 7 A 8 LEU A 168 LYS A 173 -1 O GLU A 170 N HIS A 158 SHEET 8 A 8 HIS A 195 LYS A 200 1 O VAL A 197 N VAL A 171 SHEET 1 B 8 ILE B 88 SER B 91 0 SHEET 2 B 8 THR B 40 VAL B 44 1 N VAL B 41 O ALA B 89 SHEET 3 B 8 HIS B 17 ILE B 21 1 N VAL B 20 O VAL B 44 SHEET 4 B 8 LEU B 103 GLU B 106 1 O LEU B 103 N THR B 19 SHEET 5 B 8 ILE B 131 SER B 134 1 O ALA B 133 N GLU B 106 SHEET 6 B 8 PHE B 154 HIS B 158 1 O ALA B 155 N PHE B 132 SHEET 7 B 8 LEU B 168 LYS B 173 -1 O GLU B 170 N HIS B 158 SHEET 8 B 8 HIS B 195 LYS B 200 1 O VAL B 197 N VAL B 171 CISPEP 1 ASN A 161 PRO A 162 0 -0.46 CISPEP 2 ASN B 161 PRO B 162 0 -0.26 SITE 1 AC1 13 GLY A 24 LEU A 25 MET A 26 ASP A 45 SITE 2 AC1 13 GLN A 46 ALA A 107 ILE A 108 GLN A 110 SITE 3 AC1 13 ASN A 135 SER A 137 ASN A 161 HOH A 888 SITE 4 AC1 13 HOH A 945 SITE 1 AC2 13 GLY B 24 LEU B 25 MET B 26 ASP B 45 SITE 2 AC2 13 GLN B 46 ALA B 107 ILE B 108 VAL B 109 SITE 3 AC2 13 GLN B 110 LYS B 115 ASN B 135 SER B 137 SITE 4 AC2 13 HOH B 841 CRYST1 50.020 85.950 168.505 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019992 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011635 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005935 0.00000 MASTER 320 0 2 30 16 0 8 6 0 0 0 48 END